HUTCHMED (China) Ltd (HCM) stock
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
$13.22−0.23 (-1.71%)
Close on Nov 20, 2026Market cap $2.31BP/E 5.1Yield –
HUTCHMED (China) free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
HUTCHMED (China)'s free cash flow for the twelve months ending Dec 31, 2019 was -$89.48M. For fiscal 2025 it was -$78.81M. The highest annual figure on record is $186.65M in fiscal 2023.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$78.81M | – |
| FY2024 | Dec 31, 2024 | -$17.44M | -109.3% |
| FY2023 | Dec 31, 2023 | $186.65M | – |
| FY2022 | Dec 31, 2022 | -$305.26M | – |
| FY2021 | Dec 31, 2021 | -$220.62M | – |
| FY2020 | Dec 31, 2020 | -$70.02M | – |
| FY2019 | Dec 31, 2019 | -$89.48M | – |
| FY2018 | Dec 31, 2018 | -$39.21M | – |
| FY2017 | Dec 31, 2017 | -$13.96M | – |
| FY2016 | Dec 31, 2016 | -$13.90M | – |
| FY2015 | Dec 31, 2015 | -$12.71M | -374.5% |
| FY2014 | Dec 31, 2014 | $4.63M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | -$20.34M | – |
| Q3 FY2019 | Sep 30, 2019 | -$35.25M | – |
| Q2 FY2019 | Jun 30, 2019 | -$3.61M | -131.4% |
| Q1 FY2019 | Mar 31, 2019 | -$30.28M | – |
| Q4 FY2018 | Dec 31, 2018 | -$16.87M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.67M | – |
| Q2 FY2018 | Jun 30, 2018 | $11.48M | – |
| Q1 FY2018 | Mar 31, 2018 | -$32.16M | – |
See a number that looks wrong?